Anand Rao
About Anand Rao
Anand Rao is the Associate Director of Market Access Analytics at Alkermes in Waltham, MA, with extensive experience in market access and analytics roles in the biotech and pharmaceutical industries.
Professional Title and Current Role
Anand Rao is the Associate Director of Market Access Analytics at Alkermes, located in Waltham, MA. He is responsible for leading analytics initiatives that drive market access strategies and improve the company's penetration within the market.
Career History at Alkermes
Anand Rao's journey at Alkermes began in 2015 when he joined as a Sr. Sales Analyst. He was promoted to Manager, Market Analytics in 2017 and later to Manager, Market Access Analytics, holding each role for over a year. His consistent performance led to his current role as Associate Director of Market Access Analytics. Through these positions, Rao has honed his expertise in sales analytics and market access, contributing significantly to the company's success in these areas.
Previous Work Experience
Before joining Alkermes, Anand Rao worked at Trinity Pharma Solutions from 2011 to 2015, initially as an Associate Business Analyst and later as a Business Analyst. His early career includes roles such as Marketing Intern at Analogic, Intern at Myomo, Inc., and Research Associate at First Light Biosciences and IQuum. Additionally, he interned at the US Army in Natick, Massachusetts from 2000 to 2002.
Educational Background
Anand Rao holds an MBA in Health Sector Management from the Questrom School of Business at Boston University, attained between 2009 and 2011. He also holds an MS in Biochemistry from the University of Massachusetts Medical School, completed from 2002 to 2005. Additionally, he earned a BS in Biological Sciences from Carnegie Mellon University, graduating in 2002. His early education was at Framingham High School, where he studied from 1994 to 1998.
Notable Achievements and Contributions
Anand Rao has been recognized for his contributions to market access analytics, including receiving the 'Excellence in Market Access Analytics' award at Alkermes in 2021. He led a cross-functional team to develop a market access strategy that resulted in a 20% increase in market penetration for a new life science product. Additionally, he presented at the 2022 Pharma Market Access Conference and published a white paper titled 'The Impact of Quantitative Analysis in Market Access'. He actively mentors junior analysts and developed a proprietary Excel model that improved forecasting accuracy by 15%.